Registration Dossier

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
(Q)SAR
Adequacy of study:
weight of evidence
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
results derived from a valid (Q)SAR model and falling into its applicability domain, with limited documentation / justification

Data source

Reference
Reference Type:
other: prediction
Title:
QSAR prediction of levonorgestrel acetate
Author:
Gedeon Richter Plc.
Year:
2016
Bibliographic source:
QSAR Toolbox

Materials and methods

Test guideline
Qualifier:
no guideline required
Principles of method if other than guideline:
QSAR

Test material

Constituent 1
Chemical structure
Reference substance name:
(17β)-13-Ethyl-17-ethynyl-3-oxogon-4-en-17-yl acetate
EC Number:
604-013-8
Cas Number:
13732-69-9
Molecular formula:
C23H30O3
IUPAC Name:
(17β)-13-Ethyl-17-ethynyl-3-oxogon-4-en-17-yl acetate

Results and discussion

In vivo (LLNA)

Results
Parameter:
EC3
Value:
15.3
Remarks on result:
positive indication of skin sensitisation based on QSAR/QSPR prediction

Applicant's summary and conclusion

Interpretation of results:
Category 1B (indication of skin sensitising potential) based on GHS criteria